150 related articles for article (PubMed ID: 11248624)
21. The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: a systematic review of the literature.
Gakis G; Boorjian SA; Briganti A; Joniau S; Karazanashvili G; Karnes RJ; Mattei A; Shariat SF; Stenzl A; Wirth M; Stief CG
Eur Urol; 2014 Aug; 66(2):191-9. PubMed ID: 23735200
[TBL] [Abstract][Full Text] [Related]
22. Evaluating the predictive accuracy and the clinical benefit of a nomogram aimed to predict survival in node-positive prostate cancer patients: External validation on a multi-institutional database.
Bianchi L; Schiavina R; Borghesi M; Bianchi FM; Briganti A; Carini M; Terrone C; Mottrie A; Gacci M; Gontero P; Imbimbo C; Marchioro G; Milanese G; Mirone V; Montorsi F; Morgia G; Novara G; Porreca A; Volpe A; Brunocilla E
Int J Urol; 2018 Jun; 25(6):574-581. PubMed ID: 29633372
[TBL] [Abstract][Full Text] [Related]
23. Utility of preoperative serum prostate-specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer.
Narayan P; Fournier G; Gajendran V; Leidich R; Lo R; Wolf JS; Jacob G; Nicolaisen G; Palmer K; Freiha F
Urology; 1994 Oct; 44(4):519-24. PubMed ID: 7524237
[TBL] [Abstract][Full Text] [Related]
24. Model to predict prostate biopsy outcome in large screening population with independent validation in referral setting.
Porter CR; Gamito EJ; Crawford ED; Bartsch G; Presti JC; Tewari A; O'Donnell C
Urology; 2005 May; 65(5):937-41. PubMed ID: 15882727
[TBL] [Abstract][Full Text] [Related]
25. Algorithm for selecting men for pelvic lymph node dissection (PLND) during radical prostatectomy based on clinical risk factors in an Australian population.
Sengupta S; Weerakoon M; Sethi K; Ischia J; Webb DR
BJU Int; 2012 Apr; 109 Suppl 3():48-51. PubMed ID: 22458494
[TBL] [Abstract][Full Text] [Related]
26. Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathological Research Group for Localized Prostate Cancer.
Naito S; Kuroiwa K; Kinukawa N; Goto K; Koga H; Ogawa O; Murai M; Shiraishi T;
J Urol; 2008 Sep; 180(3):904-9; discussion 909-10. PubMed ID: 18635221
[TBL] [Abstract][Full Text] [Related]
27. Can side-specific biopsy findings predict the side of nodal metastasis in clinically localized prostate cancer? Results from a multicenter prospective survey.
Schiavina R; Gacci M; Briganti A; Imbimbo C; Simonato A; Borghesi M; Capitanio U; Brunocilla E; Martorana G; Carini M; Montorsi F; Mirone V; Carmignani G
Eur J Surg Oncol; 2013 Sep; 39(9):1019-24. PubMed ID: 23838373
[TBL] [Abstract][Full Text] [Related]
28. Prediction of Micrometastasis (< 1 cm) to Pelvic Lymph Nodes in Prostate Cancer: Role of Preoperative MRI.
Park SY; Oh YT; Jung DC; Cho NH; Choi YD; Rha KH
AJR Am J Roentgenol; 2015 Sep; 205(3):W328-34. PubMed ID: 26295669
[TBL] [Abstract][Full Text] [Related]
29. An artificial neural network for prostate cancer staging when serum prostate specific antigen is 10 ng./ml. or less.
Zlotta AR; Remzi M; Snow PB; Schulman CC; Marberger M; Djavan B
J Urol; 2003 May; 169(5):1724-8. PubMed ID: 12686818
[TBL] [Abstract][Full Text] [Related]
30. Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patients.
Douglas TH; Morgan TO; McLeod DG; Moul JW; Murphy GP; Barren R; Sesterhenn IA; Mostofi FK
Cancer; 1997 Jul; 80(1):107-14. PubMed ID: 9210715
[TBL] [Abstract][Full Text] [Related]
31. [Problems of the preoperative prediction of the pathological stage in prostate cancer].
Konomoto T; Naito S
Gan To Kagaku Ryoho; 2003 Jan; 30(1):21-5. PubMed ID: 12557700
[TBL] [Abstract][Full Text] [Related]
32.
Herlemann A; Wenter V; Kretschmer A; Thierfelder KM; Bartenstein P; Faber C; Gildehaus FJ; Stief CG; Gratzke C; Fendler WP
Eur Urol; 2016 Oct; 70(4):553-557. PubMed ID: 26810345
[TBL] [Abstract][Full Text] [Related]
33. Reliability of sentinel node procedure for lymph node staging in prostate cancer patients at high risk for lymph node involvement.
Van den Bergh L; Joniau S; Haustermans K; Deroose CM; Isebaert S; Oyen R; Mottaghy FM; Ameye F; Berkers J; Van Poppel H; Lerut E
Acta Oncol; 2015 Jun; 54(6):896-902. PubMed ID: 25591936
[TBL] [Abstract][Full Text] [Related]
34. Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection.
Briganti A; Karakiewicz PI; Chun FK; Suardi N; Gallina A; Abdollah F; Freschi M; Doglioni C; Rigatti P; Montorsi F
Int J Urol; 2009 Aug; 16(8):676-81. PubMed ID: 19602006
[TBL] [Abstract][Full Text] [Related]
35. Yonsei nomogram to predict lymph node invasion in Asian men with prostate cancer during robotic era.
Kim KH; Lim SK; Kim HY; Han WK; Choi YD; Chung BH; Hong SJ; Rha KH
BJU Int; 2014 Apr; 113(4):598-604. PubMed ID: 24006951
[TBL] [Abstract][Full Text] [Related]
36. Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer.
van Leeuwen PJ; Emmett L; Ho B; Delprado W; Ting F; Nguyen Q; Stricker PD
BJU Int; 2017 Feb; 119(2):209-215. PubMed ID: 27207581
[TBL] [Abstract][Full Text] [Related]
37. Genetic adaptive neural network to predict biochemical failure after radical prostatectomy: a multi-institutional study.
Tewari A; Issa M; El-Galley R; Stricker H; Peabody J; Pow-Sang J; Shukla A; Wajsman Z; Rubin M; Wei J; Montie J; Demers R; Johnson CC; Lamerato L; Divine GW; Crawford ED; Gamito EJ; Farah R; Narayan P; Carlson G; Menon M
Mol Urol; 2001; 5(4):163-9. PubMed ID: 11790278
[TBL] [Abstract][Full Text] [Related]
38. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.
Partin AW; Kattan MW; Subong EN; Walsh PC; Wojno KJ; Oesterling JE; Scardino PT; Pearson JD
JAMA; 1997 May; 277(18):1445-51. PubMed ID: 9145716
[TBL] [Abstract][Full Text] [Related]
39. Laparoscopic extended pelvic lymph node (LN) dissection as validation of the performance of [(11) C]-acetate positron emission tomography/computer tomography in the detection of LN metastasis in intermediate- and high-risk prostate cancer.
Daouacher G; von Below C; Gestblom C; Ahlström H; Grzegorek R; Wassberg C; Sörensen J; Waldén M
BJU Int; 2016 Jul; 118(1):77-83. PubMed ID: 26074275
[TBL] [Abstract][Full Text] [Related]
40. Does increasing the nodal yield improve outcomes in contemporary patients without nodal metastasis undergoing radical prostatectomy?
Kluth LA; Xylinas E; Rieken M; Chun FK; Fajkovic H; Becker A; Karakiewicz PI; Passoni N; Herman M; Lotan Y; Seitz C; Schramek P; Remzi M; Loidl W; Guillonneau B; Rouprêt M; Briganti A; Scherr DS; Graefen M; Tewari AK; Shariat SF
Urol Oncol; 2014 Jan; 32(1):47.e1-8. PubMed ID: 24055425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
